Seroatlas · Human Serome Atlas

ERLN

Endoregulin

Also known as: C17orf110, ELN, ERLN_HUMAN, SMIM6

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P0DI80
Gene
ERLN
Ensembl
ENSG00000259120
Chromosome
17
Canonical length
62 aa
Protein class
Predicted membrane proteins, Transporters
Subcellular location
Nucleoplasm
Quaternary structure
Homooligomer

OverviewNCBI Gene

Predicted to act upstream of or within negative regulation of ATPase-coupled calcium transmembrane transporter activity. Predicted to be located in endoplasmic reticulum membrane. [provided by Alliance of Genome Resources, Jul 2025]

Canonical amino-acid sequenceUniProt

62 residues, UniProt reviewed canonical sequence.

>P0DI80|ERLN
     1  MDQLVFKETI WNDAFWQNPW DQGGLAVIIL FITAVLLLIL FAIVFGLLTS TENTQCEAGE
    61  EE

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ERLN can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Other membrane
Secreted
No
Transmembrane segments
1
Mean surface accessibility (rSASA)
0.54
Highest tissue expression
31 nTPM

Expression across tissuesHPA

Tissue

  • stomach: 31 nTPM
  • testis: 25 nTPM
  • fallopian tube: 23 nTPM
  • kidney: 22 nTPM
  • spinal cord: 12 nTPM
  • gallbladder: 9 nTPM

Single-cell type

  • late spermatids: 1,696 nCPM
  • early spermatids: 659 nCPM
  • epididymal clear cells: 182 nCPM
  • endometrial ciliated cells: 181 nCPM
  • fallopian tube ciliated cells: 154 nCPM
  • neuroendocrine cells: 125 nCPM

Immune cell

  • plasmacytoid DC: 34 nTPM
  • NK-cell: 0.8 nTPM
  • total PBMC: 0.3 nTPM
  • myeloid DC: 0.2 nTPM
  • basophil: 0 nTPM
  • classical monocyte: 0 nTPM

Brain region

  • white matter: 14 nTPM
  • pons: 10 nTPM
  • basal ganglia: 9.9 nTPM
  • medulla oblongata: 9.7 nTPM
  • midbrain: 9.6 nTPM
  • cerebellum: 8.2 nTPM

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.87
gnomAD pLI
0
DepMap mean gene effect
0.03
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Cellular components

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of ERLN in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ERLN as an antibody target. Whether an autoantibody or antibody against ERLN could matter depends on whether native ERLN is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ERLN is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label ERLN as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/ERLN. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...